KC
ZBH icon

Kepos Capital’s Zimmer Biomet ZBH Stock Holding History

Kepos Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-51,299
Closed -$6.55M – 415
2018
Q3 		$6.55M Buy
51,299
+6,418
+14% +$763K 0.34% 58
2018
Q2 		$4.86M Hold
44,881
– – 0.25% 100
2018
Q1 		$4.75M Buy
+44,881
New +$5.21M 0.28% 82

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kepos Capital's ZBH Position: Q4 2018 in Review

Kepos Capital sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 51,299 shares — an estimated $6.55M sold.

Kepos Capital first reported a position in ZBH in Q1 2018 and held it in 3 quarters. The position peaked at $6.55M in Q3 2018. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

  • Kepos Capital reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
  • Kepos Capital sold 51,299 Zimmer Biomet shares in Q4 2018, an estimated $6.55M.
  • Kepos Capital first reported a position in Zimmer Biomet in Q1 2018 and held it in 3 quarters.
  • Kepos Capital's Zimmer Biomet position peaked at $6.55M in Q3 2018.
  • 871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Kepos Capital's 13F filing for Q4 2018, filed 13 Feb 2019.